Amiodarone as a possible therapy for coronavirus infection

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

(2020) Jasper Fuk-Woo Chan et al.   Emerging Microbes & Infections

OUP accepted manuscript

(2018)   JOURNAL OF INFECTIOUS DISEASES

Antiviral activity of cationic amphiphilic drugs

(2017) Cristiano Salata et al.   Expert Review of Anti-Infective Therapy

Progression of Ebola Therapeutics During the 2014–2015 Outbreak

(2016) Emelissa J. Mendoza et al.   TRENDS IN MOLECULAR MEDICINE

Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care

(2015) Timo Wolf et al.   LANCET

Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process

(2015) Cristiano Salata et al.   Pathogens and Disease

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

(2014) Gerrit Gehring et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle

(2013) Yuan-Lung Cheng et al.   CLINICAL SCIENCE

Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post-Endosomal Level

(2008) Konrad Stadler et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY